NeuroSense Therapeutics L... (NRSN)
NASDAQ: NRSN
· Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.19
-0.42%
After-hours: Aug 15, 2025, 04:10 PM EDT
NeuroSense Therapeutics Fail-to-Deliver
Total FTD Shares
5.07K
Below Average
FTD / Avg. Volume
1.35%
Low Impact
1-Year Change
> 100%
Positive Trend
FTD Chart
As of Jul 11, 2025,
NeuroSense Therapeutics Ltd. has
5,071
shares failed to deliver, representing 1.35%
of the average daily volume of
374,632
shares. Over the past year, the monthly average FTD is
7,997
shares, with the current level 37% below
the historical average, indicating
moderate
settlement pressure. The weighted FTD ratio above 1% suggests potential liquidity constraints or heightened short-selling activity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 11, 2025 | 2.07 | 5.07K | -83.49% |
| Jun 30, 2025 | 1.89 | 30.71K | +669.80% |
| May 30, 2025 | 1.54 | 3.99K | -19.05% |
| Apr 23, 2025 | 0.98695 | 4.93K | +215.96% |
| Mar 31, 2025 | 0.9299 | 1.56K | -60.01% |
| Feb 28, 2025 | 1.11 | 3.9K | +2789.63% |
| Jan 14, 2025 | 1.03 | 135 | -93.89% |
| Dec 24, 2024 | 1.28 | 2.21K | +60.38% |
| Nov 27, 2024 | 0.92981 | 1.38K | -67.68% |
| Oct 31, 2024 | 1.25 | 4.26K | +559.04% |
| Sep 27, 2024 | 1.28 | 647 | -98.48% |
| Aug 30, 2024 | 0.89 | 42.46K | +525.28% |
| Jul 31, 2024 | 0.7598 | 6.79K | +35.90% |
| Jun 28, 2024 | 1.12 | 5K | -14.97% |
| May 29, 2024 | 1.11 | 5.88K | +11.29% |
| Apr 26, 2024 | 1.23 | 5.28K | +39.01% |
| Mar 27, 2024 | 1.73 | 3.8K | +1523.50% |
| Feb 28, 2024 | 1.8 | 234 | -90.31% |
| Jan 31, 2024 | 1.25 | 2.41K | +58.09% |
| Dec 29, 2023 | 0.785 | 1.53K | -93.78% |
| Nov 30, 2023 | 1.29 | 24.54K | +476.82% |
| Sep 19, 2023 | 0.8275 | 4.25K | +3172.31% |
| Jun 28, 2023 | 1.5 | 130 | -98.28% |
| May 31, 2023 | 1.56 | 7.57K | -19.84% |
| Apr 28, 2023 | 2.02 | 9.44K | +1197.25% |
| Mar 23, 2023 | 1.66 | 728 | +58.95% |
| Feb 27, 2023 | 1.92 | 458 | -17.03% |
| Jan 30, 2023 | 1.57 | 552 | n/a |